ImmunoGen, Huadong Medicine ink oncology agreement for $305M

Pharma |  News | 0 Comment | 20 Oct, 2020

ImmunoGen Inc., a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, and Hang...Read more

Versantis receives FDA RPDD for treatment of urea cycle disorders

Pharma |  News | 0 Comment | 19 Oct, 2020

Versantis AG, a clinical-stage company developing novel therapies for orphan liver diseases based in Switzerland, has re...Read more

SK Biopharma takes anti-seizure medication to Japan

Pharma |  News | 0 Comment | 16 Oct, 2020

SK Biopharmaceuticals in South Korea and Japanese firm Ono Pharmaceutical announced that they have entered into an exclu...Read more

NeoGenomics to expand pharma services in China

Pharma |  News | 0 Comment | 15 Oct, 2020

NeoGenomics, Inc., a leading provider of oncology testing and global contract research services headquartered in th...Read more

Everest Medicines successfully lists on HKEX

Pharma |  News | 0 Comment | 15 Oct, 2020

China-based CBC Group, a healthcare-dedicated investment platform, celebrates the initial public offering (IPO) of Evere...Read more

Chris Hourigan steps in as Company Group Chairman for Janssen APAC

Pharma |  News | 0 Comment | 15 Oct, 2020

The Janssen Pharmaceutical Companies of Johnson & Johnson have announced that Chris Hourigan has been promoted to le...Read more

Takeda accelerates digital transformation with Accenture and AWS

Pharma |  News | 0 Comment | 14 Oct, 2020

Japanese firm Takeda Pharmaceutical has entered into a five-year strategic agreement with Accenture and Amazon Web Servi...Read more

Lilly reports reduced recovery time in critically ill COVID-19 patients with Baricitinib

Pharma |  News | 0 Comment | 12 Oct, 2020

US based Eli Lilly and Company and Incyte shared additional data showing baricitinib in combination with remdesivir...Read more

Fast-tracking innovation and transformative care to patients

Pharma |  Opinion | 0 Comment | 09 Oct, 2020

The present pandemic scenarios are continuing to place immense pressure on healthcare systems across Asia Pacific (APAC)...Read more

Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy

Pharma |  News | 0 Comment | 12 Oct, 2020

Japan-based Takeda Pharmaceutical Company Limited (Takeda) and Arrowhead Pharmaceuticals Inc. in the US have announced a...Read more

Pfizer announces positive Ph 3 results for long-acting human growth hormone

Pharma |  News | 0 Comment | 08 Oct, 2020

Pfizer Inc., an American multinational pharmaceutical corporation headquartered in New York City and OPKO Health In...Read more

U.S. FDA grants RPD to Cerecin’s investigational drug Tricaprilin

Pharma |  News | 0 Comment | 08 Oct, 2020

Cerecin, a biopharmaceutical company focused on discovering and developing brain therapeutics, announced that the U.S. F...Read more

Corvus announces co-founding of Angel Pharma in China

Pharma |  News | 0 Comment | 06 Oct, 2020

Corvus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company based in the US, has entered into a strategic c...Read more

Eisai to involve jointly in COVID-19 drug discovery utilizing Eritoran and E6011

Pharma |  News | 0 Comment | 07 Oct, 2020

Japan's Eisai has entered into a joint research agreement with four research organizations (KAN Research Institute, Nati...Read more

USFDA grants orphan drug designation to CARsgen Therapeutics

Pharma |  News | 0 Comment | 05 Oct, 2020

CARsgen Therapeutics Co., Ltd., a clinical-stage biopharmaceutical company based in China, has recently announced that&n...Read more

Korea unveils affordable method to produce pharma ingredients

Pharma |  News | 0 Comment | 06 Oct, 2020

Besides searching for novel biologically active compounds for the discovery of new drugs, it is even more...Read more

Shionogi partners with HanaVax for pneumonia vaccine candidate

Pharma |  News | 0 Comment | 05 Oct, 2020

Shionogi & Co. and HanaVax Inc., both based in Japan, have announced they have entered into a license agreement for ...Read more

Eisai, Seikagaku ink marketing agreement for osteoarthritis drug in South Korea

Pharma |  News | 0 Comment | 02 Oct, 2020

Eisai Co., Ltd. and Seikagaku Corporation, both based in Japan, have announced that the companies have entered into an a...Read more